Protenix
PulseAugur coverage of Protenix — every cluster mentioning Protenix across labs, papers, and developer communities, ranked by signal.
1 day(s) with sentiment data
-
ByteDance spin-off Anew Labs raises $290M for AI drug discovery
Anew Labs, a former unit of ByteDance, has secured US$290 million in funding at a US$1.5 billion valuation. The Shanghai-based AI drug discovery firm's funding round was backed by prominent venture capital firms includi…
-
LLMs enhance protein binder design by improving candidate shortlisting
Researchers have developed a method using LLMs to improve the selection of protein binders for design purposes. By leveraging models like GPT-4o and GPT-5.4, they can create ranking policies that combine various proxy s…
-
ByteDance spins off AI drug discovery unit for independent funding
ByteDance is spinning off its AI drug discovery division to pursue independent financing, while retaining majority control. This move aims to establish a more suitable organizational structure for the AI for Science (AI…